Spots Global Cancer Trial Database for oral cavity cancer
Every month we try and update this database with for oral cavity cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| WORST PATTERN OF INVASION IN ORAL SQUAMOUS CELL CARCINOMA | NCT05927220 | Oral Cancer Oral Cavity Can... Oral Squamous C... | Biopsy Specimen... | 18 Years - 80 Years | Armed Forces Institute of Pathology Rawalpindi | |
| Pembrolizumab in Combination With CRT for LA-SCCHN | NCT02586207 | Head and Neck C... Squamous Cell C... Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer Laryngeal Cance... | pembrolizumab (... Cisplatin Radiation | 18 Years - | Sanford Health | |
| Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae | NCT05757817 | Head and Neck C... Oral Cavity Can... Oropharynx Canc... | Oropharyngeal o... | 18 Years - | Institut Claudius Regaud | |
| Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema | NCT00951470 | Lymphedema Oropharyngeal C... Head and Neck C... Oral Cancer | Follow -Up Visi... Full CDT Modified CDT Pr... | 18 Years - | M.D. Anderson Cancer Center | |
| Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer | NCT00003489 | Head and Neck C... | Antineoplaston ... | 16 Years - 99 Years | Burzynski Research Institute | |
| Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer | NCT00824174 | Head and Neck C... Skin Cancer | Questionnaire | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of High-Risk Oral Cavity Cancer | NCT00934739 | Oral Cavity Can... | Thalidomide, Ce... Cyclophosphamid... | - 70 Years | National Health Research Institutes, Taiwan | |
| Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+ | NCT03121313 | Squamous Cell C... | tegafur-uracil | 20 Years - 70 Years | Chang Gung Memorial Hospital | |
| Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy | NCT05337631 | HNSCC Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | 65 Years - | University Hospital Freiburg | ||
| The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors | NCT05798780 | Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | ENHANCE Interve... ENHANCE Interve... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+ | NCT03121313 | Squamous Cell C... | tegafur-uracil | 20 Years - 70 Years | Chang Gung Memorial Hospital | |
| CytID Analysis of Oral Lesions | NCT03555721 | Oral Cavity Can... Oropharyngeal C... | Oral examinatio... Oral examinatio... Biopsy CytID hpvID | 18 Years - 80 Years | The University of Texas Health Science Center, Houston | |
| Immune Biomarker Study for Head and Neck Cancer | NCT05375266 | Head and Neck C... Oral Cavity Can... Oropharyngeal C... Hypopharyngeal ... Laryngeal Cance... | Sampling | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| Smoking Status and Body Image in Oral Cancer Patients | NCT00412490 | Oral Cavity Can... | Questionnaire Interview | 18 Years - | M.D. Anderson Cancer Center | |
| Adaptive Radiotherapy for Head and Neck Cancer | NCT03096808 | Head and Neck C... Paranasal Sinus... Oropharynx Canc... Oral Cavity Can... Nasopharynx Can... Larynx Cancer Hypopharynx Can... | Adaptive Radiot... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Early Feeding After Oral Cavity Reconstruction | NCT04787939 | Head and Neck C... Free Tissue Tra... | Early Feeding | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Antineoplaston Therapy in Treating Patients With Advanced Head and Neck Cancer | NCT00003489 | Head and Neck C... | Antineoplaston ... | 16 Years - 99 Years | Burzynski Research Institute | |
| Dysphagia and Quality of Life in Patients With Oral Squamous Cell Carcinoma Before and After Treatment | NCT06407570 | Oral Cavity Can... Dysphagia Quality of Life | 18 Years - | University of Aarhus | ||
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients | NCT02253238 | Head and Neck C... | Quality of Life... Health Manageme... Monitoring Devi... Symptoms Survey... Device Usabilit... | 18 Years - | M.D. Anderson Cancer Center | |
| Mandibular Reconstruction Preplanning (ViPMR) | NCT05429099 | Oral Cavity Can... Oral Cancer | Virtual Surgica... Free-Hand Surge... | 18 Years - | University of British Columbia | |
| Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema | NCT00951470 | Lymphedema Oropharyngeal C... Head and Neck C... Oral Cancer | Follow -Up Visi... Full CDT Modified CDT Pr... | 18 Years - | M.D. Anderson Cancer Center | |
| Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT01695122 | Head and Neck C... Oral Cavity Can... Oropharyngeal C... | Valproic Acid | - 65 Years | Instituto do Cancer do Estado de São Paulo | |
| Randomized Trial to Assess the Impact of a Screening Program on Upper Aerodigestive Tract Cancer Mortality in a High Risk Population | NCT00359645 | Pharynx Cancer Larynx Cancer Oral Cavity Can... Oesophageal Can... | Screening by he... | 40 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema | NCT00951470 | Lymphedema Oropharyngeal C... Head and Neck C... Oral Cancer | Follow -Up Visi... Full CDT Modified CDT Pr... | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers | NCT04892875 | Head and Neck C... Squamous Cell C... Oral Cavity Squ... Oral Cavity Can... Oropharynx Canc... Oropharynx Squa... Larynx Cancer Pharynx Cancer Hypopharynx Can... Hypopharynx Squ... | Zimberelimab Etrumadenant Cisplatin Radiation | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Cell-free Tumor DNA in Head and Neck Cancer Patients | NCT03942380 | Head and Neck C... Head and Neck N... Head and Neck S... Oropharynx Canc... Oropharynx Neop... Oropharynx Carc... Oral Cavity Can... Oral Cancer Oral Neoplasm Larynx Cancer Larynx Carcinom... Larynx Neoplasm Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Neo... Hypopharynx Can... Hypopharynx Neo... Hypopharynx Car... Sinonasal Carci... Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Salivary Gland ... Salivary Gland ... Salivary Gland ... Sinonasal Cance... Sinonasal Neopl... | Liquid biopsy | 18 Years - | Rigshospitalet, Denmark | |
| NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy | NCT03589339 | Radiotherapy Immunotherapy Microsatellite ... Metastasis From... Squamous Cell C... Metastasis From... Metastatic Rena... Metastasis From... Metastatic Trip... Metastatic NSCL... Metastasis From... | NBTXR3 SABR Nivolumab Pembrolizumab | 18 Years - | Nanobiotix | |
| NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx | NCT01946867 | Head and Neck C... | NBTXR3 activate... | 65 Years - | Nanobiotix | |
| Multi-Site Trial of Navigation vs Treatment as Usual for Delays in Starting Adjuvant Therapy | NCT05793151 | Head and Neck C... Head and Neck S... Oropharynx Canc... Oral Cavity Can... Larynx Cancer | ENDURE | 18 Years - | Medical University of South Carolina | |
| CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas | NCT02981862 | Cervical Cancer Vulvar Cancer Anal Cancer Oropharynx Canc... Oral Cavity Can... Penis Cancer | CaptHPV method | 18 Years - | Institut de Cancérologie de Lorraine | |
| Early Feeding After Oral Cavity Reconstruction | NCT04787939 | Head and Neck C... Free Tissue Tra... | Early Feeding | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization | NCT04065737 | Oral Cavity Can... Mouth Neoplasm Precancerous Co... | Sintilimab | 18 Years - | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
| Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma | NCT03082534 | HNSCC Lip SCC Oral Cavity Can... Oropharynx Canc... Larynx Cancer Hypopharynx Can... Nasopharynx Can... Sinonasal Carci... Cutaneous Squam... Head and Neck N... Head and Neck C... Head and Neck S... | Pembrolizumab, ... | 18 Years - | University of California, San Diego | |
| A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers | NCT04892875 | Head and Neck C... Squamous Cell C... Oral Cavity Squ... Oral Cavity Can... Oropharynx Canc... Oropharynx Squa... Larynx Cancer Pharynx Cancer Hypopharynx Can... Hypopharynx Squ... | Zimberelimab Etrumadenant Cisplatin Radiation | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer | NCT01914900 | Locally Advance... | docetaxel, cisp... | 18 Years - 99 Years | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy | NCT03589339 | Radiotherapy Immunotherapy Microsatellite ... Metastasis From... Squamous Cell C... Metastasis From... Metastatic Rena... Metastasis From... Metastatic Trip... Metastatic NSCL... Metastasis From... | NBTXR3 SABR Nivolumab Pembrolizumab | 18 Years - | Nanobiotix | |
| A Study of High-Risk Oral Cavity Cancer | NCT00934739 | Oral Cavity Can... | Thalidomide, Ce... Cyclophosphamid... | - 70 Years | National Health Research Institutes, Taiwan | |
| Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment | NCT01116843 | Oral Cavity Can... | PF-00299804 | 18 Years - | University Health Network, Toronto | |
| The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors | NCT05798780 | Oral Cavity Can... Oropharynx Canc... Hypopharynx Can... Larynx Cancer | ENHANCE Interve... ENHANCE Interve... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers | NCT04809324 | Oral Cavity Can... | Gross examinati... Frozen section | 18 Years - 100 Years | Tata Memorial Centre | |
| CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas | NCT02981862 | Cervical Cancer Vulvar Cancer Anal Cancer Oropharynx Canc... Oral Cavity Can... Penis Cancer | CaptHPV method | 18 Years - | Institut de Cancérologie de Lorraine | |
| Valproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma | NCT01695122 | Head and Neck C... Oral Cavity Can... Oropharyngeal C... | Valproic Acid | - 65 Years | Instituto do Cancer do Estado de São Paulo | |
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients | NCT02253238 | Head and Neck C... | Quality of Life... Health Manageme... Monitoring Devi... Symptoms Survey... Device Usabilit... | 18 Years - | M.D. Anderson Cancer Center | |
| Mandibular Reconstruction Preplanning (ViPMR) | NCT05429099 | Oral Cavity Can... Oral Cancer | Virtual Surgica... Free-Hand Surge... | 18 Years - | University of British Columbia | |
| Radio/Pathological Evaluation of Tongue Cancer Infiltration | NCT04821128 | Oral Squamous Cell Carcinoma | Radiologic and ... | - | Hospices Civils de Lyon | |
| Smoking Status and Body Image in Oral Cancer Patients | NCT00412490 | Oral Cavity Can... | Questionnaire Interview | 18 Years - | M.D. Anderson Cancer Center | |
| Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae | NCT05757817 | Head and Neck C... Oral Cavity Can... Oropharynx Canc... | Oropharyngeal o... | 18 Years - | Institut Claudius Regaud | |
| A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers | NCT04892875 | Head and Neck C... Squamous Cell C... Oral Cavity Squ... Oral Cavity Can... Oropharynx Canc... Oropharynx Squa... Larynx Cancer Pharynx Cancer Hypopharynx Can... Hypopharynx Squ... | Zimberelimab Etrumadenant Cisplatin Radiation | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients | NCT02253238 | Head and Neck C... | Quality of Life... Health Manageme... Monitoring Devi... Symptoms Survey... Device Usabilit... | 18 Years - | M.D. Anderson Cancer Center | |
| Screening for Cancers in the Oral CAvity | NCT01958762 | Oral Cavity Can... | Invitation for ... | 30 Years - 75 Years | Centre Hospitalier Universitaire, Amiens | |
| Feasibility of CTCs Isolation for Transcriptomes and Genome Wide Associated Analysis in Post-OP High Risk OSCC Patients. | NCT03917524 | Oral Cavity Squ... | 20 Years - | Chang Gung Memorial Hospital | ||
| Cell-free Tumor DNA in Head and Neck Cancer Patients | NCT03942380 | Head and Neck C... Head and Neck N... Head and Neck S... Oropharynx Canc... Oropharynx Neop... Oropharynx Carc... Oral Cavity Can... Oral Cancer Oral Neoplasm Larynx Cancer Larynx Carcinom... Larynx Neoplasm Nasopharyngeal ... Nasopharyngeal ... Nasopharynx Neo... Hypopharynx Can... Hypopharynx Neo... Hypopharynx Car... Sinonasal Carci... Thyroid Carcino... Thyroid Cancer Thyroid Neoplas... Salivary Gland ... Salivary Gland ... Salivary Gland ... Sinonasal Cance... Sinonasal Neopl... | Liquid biopsy | 18 Years - | Rigshospitalet, Denmark | |
| Integrated Cancer Repository for Cancer Research | NCT02012699 | Pancreatic Canc... Thyroid Cancer Lung Cancer Esophageal Canc... Thymus Cancer Colon Cancer Rectal Cancer Gastrointestina... Anal Cancer Bile Duct Cance... Duodenal Cancer Gallbladder Can... Gastric Cancer Liver Cancer Small Intestine... Peritoneal Surf... Familial Adenom... Lynch Syndrome Bladder Cancer Kidney Cancer Penile Cancer Prostate Cancer Testicular Canc... Ureter Cancer Urethral Cancer Hypopharyngeal ... Laryngeal Cance... Lip Cancer Oral Cavity Can... Nasopharyngeal ... Oropharyngeal C... Paranasal Sinus... Nasal Cavity Ca... Salivary Gland ... Skin Cancer Central Nervous... Central Nervous... Mesothelioma Breast Cancer Leukemia Melanoma Sarcoma Unknown Primary... Multiple Myelom... Ovarian Cancer Endometrial Can... Vaginal Cancer Neuroendocrine ... Plasma Cell Dys... Healthy Control | 19 Years - 110 Years | University of Nebraska | ||
| Establishing Lymphedema and Fibrosis Measures in Oral Cancer Patients | NCT02412241 | Oral Cavity Can... Oropharyngeal C... Lymphedema Fibrosis | LEF measures Technical measu... Technical measu... | 21 Years - | Vanderbilt-Ingram Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
